Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model

Brain Research

Volumn 1010, Issue 1-2, 2004, Pages 144-150

  Suyama, Hidemichi ^a   Kawamoto, Masashi ^a   Gaus, Syafruddin ^a   Yuge, Osafumi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cyclooxigenase 2 inhibitor; Etodolac; Neuropathic osteoporosis; Neuropathic pain; Rat

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; HYPERALGESIA; MULTINUCLEAR CELL; NERVE COMPRESSION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SCIATIC NEUROPATHY; THERMAL EXPOSURE; TIBIA; WITHDRAWAL REFLEX;

ACID PHOSPHATASE; ANIMALS; BONE DENSITY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; ETODOLAC; HYPERALGESIA; ISOENZYMES; LIGATION; NEURALGIA; OSTEOCLASTS; OSTEOPOROSIS; PAIN MEASUREMENT; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SCIATIC NEUROPATHY; UP-REGULATION;

EID: 2342503289     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.03.014     Document Type: Article

References (34)

1. Barton S.F., Langeland F.F., Snabes M.C., LeComte D., Kuss M.E., Dhadda S.S., Hubbard R.C. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology. 97:2002;306-314
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107
3. Bensen W.G., Fiechtner J.J., McMillen J.I., Zhao W.W., Yu S.S., Woods E.M., Hubbard R.C., Isakson P.C., Verburg K.M., Geis G.S. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin. Proc. 74:1999;1095-1105
4. Boni J., Korth-Bradley J., McGoldrick K., Appel A., Cooper S. Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. J. Clin. Pharmacol. 39:1999;729-737
5. Buritova J., Honore P., Chapman V., Besson J.M. Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat. Pain. 64:1996;559-568
6. Cole A.A., Walters L.M. Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. J. Histochem. Cytochem. 35:1987;203-206
7. Daemen M.A., Kurvers H.A., Kitslaar P.J., Slaaf D.W., Bullens P.H., Van den Wildenberg F.A. Neurogenic inflammation in an animal model of neuropathic pain. Neurol. Res. 20:1998;41-45
8. Day R., Morrison B., Luza A., Castaneda O., Strusberg A., Nahir M., Helgetveit K.B., Kress B., Daniels B., Bolognese J., Krupa D., Seidenberg B., Ehrich E. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs. ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group. Arch. Intern. Med. 160:2000;1781-1787
9. Feng L., Sun W., Xia Y., Tang W.W., Chanmugam P., Soyoola E., Wilson C.B., Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 307:1993;361-368
10. Freshwater J.D., Svensson C.I., Malmberg A.B., Calcutt N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes. 51:2002;2249-2255
11. Gordon S.M., Brahim J.S., Rowan J., Kent A., Dionne R.A. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. Clin. Pharmacol. Ther. 72:2002;175-183
12. Hains B.C., Yucra J.A., Hulsebosch C.E. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J. Neurotrauma. 18:2001;409-423
13. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88
14. Hempenstall K., Rice A.S. Current treatment options in neuropathic pain. Curr. Opin. Investig. Drugs. 3:2002;441-448
15. Immer F.F., Immer-Bansi A.S., Trachsel N., Berdat P.A., Eigenmann V., Curatolo M., Carrel T.P. Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial. Ann. Thorac. Surg. 75:2003;490-495
16. Kawaguchi H., Pilbeam C.C., Harrison J.R., Raisz L.G. The role of prostaglandins in the regulation of bone metabolism. Clin. Orthop. 313:1995;36-46
17. Kroin J.S., Buvanendran A., McCarthy R.J., Hemmati H., Tuman K.J. Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model. Reg. Anesth. Pain Med. 27:2002;451-455
18. Lashbrook J.M., Ossipov M.H., Hunter J.C., Raffa R.B., Tallarida R.J., Porreca F. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats. Pain. 82:1999;65-72
19. Ma W., Eisenach J.C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur. J. Neurosci. 15:2002;1037-1047
20. Matsumoto A.K., Melian A., Mandel D.R., McIlwain H.H., Borenstein D., Zhao P.L., Lines C.R., Gertz B.J., Curtis S. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. J. Rheumatol. 29:2002;1623-1630
21. Mazario J., Gaitan G., Herrero J.F. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology. 40:2001;937-946
22. Okamoto K., Martin D.P., Schmelzer J.D., Mitsui Y., Low P.A. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp. Neurol. 169:2001;386-391
23. Ripamonti C., Ticozzi C., Zecca E., Rodriguez C.H., De Conno F. Continuous subcutaneous infusion of ketorolac in cancer neuropathic pain unresponsive to opioid and adjuvant drugs. A case report. Tumori. 82:1996;413-415
24. Schafers M., Marziniak M., Sorkin L.S., Yaksh T.L., Sommer C. Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp. Neurol. 185:2004;160-168
25. Simon A.M., Manigrasso M.B., O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17:2002;963-976
26. Smith W.L., Marnett L.J., Dewitt D.C. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 49:1991;153-179
27. Suyama H., Gaus S., Moriwaki K., Kawamoto M., Yuge O. Effect of COX2 inhibitor (etodorac) on neuropathic pain in a rat model. Anesthesiology. 93:2000;A-931. (www.asa-abstracts.com)
28. Suyama H., Moriwaki K., Niida S., Maehara Y., Kawamoto M., Yuge O. Osteoporosis following chronic constriction injury of sciatic nerve in rats. J. Bone Miner. Metab. 20:2002;91-97
29. Tai H., Miyaura C., Pilbeam C.C., Tamura T., Ohsugi Y., Koishihara Y., Kubodera N., Kawaguchi H., Raisz L.G., Suda T. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology. 138:1997;2372-2379
30. Tang J., Li S., White P.F., Chen X., Wender R.H., Quon R., Sloninsky A., Naruse R., Kariger R., Webb T., Norel E. Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology. 96:2002;1305-1309
31. Wagner R., Janjigian M., Myers R.R. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain. 74:1998;35-42
32. Yamamoto T., Nozaki-Taguchi N. The role of cyclooxygenase-1 and -2 in the rat formalin test. Anesth. Analg. 94:2002;962-967
33. Yamamoto T., Sakashita Y., Nozaki-Taguchi N. Anti-allodynic effects of oral COX-2 selective inhibitor on postoperative pain in the rat. Can. J. Anaesth. 47:2000;354-360
34. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109:2002;1405-1415